# JUND

## Overview
The JUND gene encodes the JunD proto-oncogene, a subunit of the activator protein-1 (AP-1) transcription factor complex, which is integral to the regulation of gene expression in response to a variety of cellular stimuli. JunD is characterized by its basic leucine zipper (bZIP) domain, which facilitates dimerization and DNA binding, allowing it to function as a transcription factor. Unlike other AP-1 family members, JunD is not subject to ubiquitin-mediated degradation, which contributes to its stability and prolonged activity within the cell (Hernandez2008Multiple). The protein plays a pivotal role in cellular processes such as proliferation, differentiation, and apoptosis, and is involved in the regulation of genes critical for cell cycle progression and tissue-specific functions, such as the transition of the myometrium during pregnancy (Nicolaides1992The; Khader2024JUND). JunD's interactions with other proteins, including tumor suppressors and hormone receptors, underscore its significance in both normal physiology and disease states, particularly in various lymphoid neoplasms and cancers (Papoudou-Bai2016Expression; Aronheim1997Isolation).

## Structure
The JunD protein, a member of the AP-1 transcription factor family, is characterized by a basic leucine zipper (bZIP) domain, which facilitates dimerization and DNA binding. This domain allows JunD to form both homodimers and heterodimers with other AP-1 family members, enabling it to bind to the palindromic DNA sequence TGAC/GTCA, known as the TPA-response element (TRE) (Hernandez2008Multiple).

JunD is distinct from other AP-1 family members due to its unique regulatory mechanisms. It is not subject to ubiquitin-mediated degradation, contributing to its longer half-life. The stability and activity of JunD are influenced by post-translational modifications, such as phosphorylation by JNK and ERK pathways. Phosphorylation sites at serines 90 and 100 and threonine 117 are crucial for its function (Hernandez2008Multiple).

The JunD protein also contains a δ-like domain that is inefficiently ubiquitinated, and it lacks a JNK binding region, which affects its ubiquitination (Hernandez2008Multiple). Additionally, JunD has a regulatory domain motif, LKDEP (amino acids 233-237), which is a putative sumoylation site conserved in c-Jun and JunB (Hernandez2008Multiple). The protein exists in two isoforms due to alternative translation initiation, resulting in a full-length 39-kDa protein and a 34-kDa protein lacking 43 amino acids at the N-terminus (Hernandez2008Multiple).

## Function
The JUND gene encodes a protein that is a component of the AP-1 transcription factor complex, which plays a crucial role in regulating gene expression in response to various stimuli. JUND is involved in several molecular processes, including the regulation of cell proliferation, differentiation, and apoptosis. It functions by forming dimers with other proteins, such as members of the Fos and ATF families, to bind specific DNA elements and regulate transcription (Thépot2000Targeted).

In healthy human cells, JUND is implicated in the regulation of the c-myb proto-oncogene, which is essential for cell cycle progression, particularly in hematopoietic cells. JUND, along with c-Jun, enhances the expression of the c-myb gene by binding to an AP1-like element in its promoter region, facilitating the positive autoregulation of c-myb expression during the G1/S transition of the cell cycle (Nicolaides1992The).

JUND also plays a significant role in the transition of the myometrium from a quiescent to a contractile state during pregnancy. It regulates the expression of contraction-associated genes, preparing the myometrium for labor onset. JUND is enriched in non-laboring myometrial tissues, indicating its role in maintaining uterine quiescence throughout gestation (Khader2024JUND).

## Clinical Significance
JUND, a member of the activator protein-1 (AP-1) transcription factor family, plays a significant role in the pathogenesis of various lymphoid neoplasms. In adult T cell leukemia/lymphoma (ATL), JUND is highly expressed in primary ATL cells, promoting cell proliferation. Knockdown of JUND using siRNA reduces cell growth in ATL cells, indicating its critical role in the disease's progression (Papoudou-Bai2016Expression). JUND also activates the SOX4 promoter, which is consistently expressed in ATL cells, further contributing to their growth (Papoudou-Bai2016Expression).

In splenic marginal zone lymphoma (SMZL), JUND is upregulated, suggesting its involvement in the oncogenesis of this lymphoma type. The upregulation of IL-6 mRNA, regulated by AP-1 transcription factors, is also noted in SMZL cases (Papoudou-Bai2016Expression). In diffuse large B cell lymphomas (DLBCL), JUND expression is prevalent and is associated with tumor cell proliferation markers, indicating its role in the aggressive phenotype of these lymphomas (Papoudou-Bai2016Expression).

JUND's involvement extends to cutaneous lymphomas, where its deregulation may result from genomic amplification and constitutive activation of ERK1/2 MAPK, contributing to the pathogenesis of these lymphomas (Papoudou-Bai2016Expression).

## Interactions
JunD, a component of the AP-1 transcription factor complex, participates in various protein-protein interactions that influence its role in gene regulation. It forms heterodimeric complexes with other AP-1 proteins such as c-Jun, JunB, and JDP2, which can modulate transcriptional activity. JDP2, for instance, interacts with JunD to repress AP-1 transcriptional activation (Aronheim1997Isolation).

JunD also interacts with menin, a tumor suppressor protein. This interaction is crucial for the repression of JunD's transcriptional activity by menin. Specific amino acids in the N-terminal region of JunD, such as P41, G42, and P44, are essential for binding to menin. Mutations in these residues can disrupt the interaction, affecting JunD's transcriptional regulation (Knapp2000Identification).

In the context of prostate cancer, JunD interacts with the androgen receptor (AR) to regulate the expression of genes like Spermidine/Spermine N1-Acetyl Transferase (SSAT), which is involved in reactive oxygen species production. Inhibitors targeting the AR-JunD interaction have been identified, highlighting the potential therapeutic significance of disrupting this interaction to prevent cancer progression (MehraeinGhomi2014Targeting).

JunD also interacts with CHOP, a member of the C/EBP family, through their leucine zipper domains. This interaction enhances the transcriptional activity of JunD, demonstrating its role in gene activation (Ubeda1999CHOP).


## References


[1. (Papoudou-Bai2016Expression) Alexandra Papoudou-Bai, Eleftheria Hatzimichael, Alexandra Barbouti, and Panagiotis Kanavaros. Expression patterns of the activator protein-1 (ap-1) family members in lymphoid neoplasms. Clinical and Experimental Medicine, 17(3):291–304, September 2016. URL: http://dx.doi.org/10.1007/s10238-016-0436-z, doi:10.1007/s10238-016-0436-z. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10238-016-0436-z)

[2. (Aronheim1997Isolation) Ami Aronheim, Ebrahim Zandi, Hanjo Hennemann, Stephen J. Elledge, and Michael Karin. Isolation of an ap-1 repressor by a novel method for detecting protein-protein interactions. Molecular and Cellular Biology, 17(6):3094–3102, June 1997. URL: http://dx.doi.org/10.1128/mcb.17.6.3094, doi:10.1128/mcb.17.6.3094. This article has 374 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.17.6.3094)

[3. (Thépot2000Targeted) Dominique Thépot, Jonathan B. Weitzman, Jacqueline Barra, Dominique Segretain, Marie-Georges Stinnakre, Charles Babinet, and Moshe Yaniv. Targeted disruption of the murine jund gene results in multiple defects in male reproductive function. Development, 127(1):143–153, January 2000. URL: http://dx.doi.org/10.1242/dev.127.1.143, doi:10.1242/dev.127.1.143. This article has 111 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.127.1.143)

[4. (MehraeinGhomi2014Targeting) Farideh Mehraein-Ghomi, Stacy J. Kegel, Dawn R. Church, Joseph S. Schmidt, Quentin R. Reuter, Elizabeth L. Saphner, Hirak S. Basu, and George Wilding. Targeting androgen receptor and jund interaction for prevention of prostate cancer progression: inhibitors of ar-jund interaction in prostate cancer. The Prostate, 74(7):792–803, March 2014. URL: http://dx.doi.org/10.1002/pros.22800, doi:10.1002/pros.22800. This article has 9 citations.](https://doi.org/10.1002/pros.22800)

5. (Khader2024JUND) JUND plays a genome-wide role in the quiescent to contractile switch in the pregnant human myometrium. This article has 0 citations.

[6. (Hernandez2008Multiple) J M Hernandez, D H Floyd, K N Weilbaecher, P L Green, and K Boris-Lawrie. Multiple facets of jund gene expression are atypical among ap-1 family members. Oncogene, 27(35):4757–4767, April 2008. URL: http://dx.doi.org/10.1038/onc.2008.120, doi:10.1038/onc.2008.120. This article has 102 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2008.120)

[7. (Nicolaides1992The) N.C. Nicolaides, I Correa, C Casadevall, S Travali, K.J. Soprano, and B Calabretta. The jun family members, c-jun and jund, transactivate the human c-myb promoter via an ap1-like element. Journal of Biological Chemistry, 267(27):19665–19672, September 1992. URL: http://dx.doi.org/10.1016/s0021-9258(18)41826-1, doi:10.1016/s0021-9258(18)41826-1. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)41826-1)

[8. (Knapp2000Identification) J I Knapp, C Heppner, A B Hickman, A L Burns, S C Chandrasekharappa, F S Collins, S J Marx, A M Spiegel, and S K Agarwal. Identification and characterization of jund missense mutants that lack menin binding. Oncogene, 19(41):4706–4712, September 2000. URL: http://dx.doi.org/10.1038/sj.onc.1203832, doi:10.1038/sj.onc.1203832. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1203832)

[9. (Ubeda1999CHOP) Mariano Ubeda, Mario Vallejo, and Joel F. Habener. Chop enhancement of gene transcription by interactions with jun/fos ap-1 complex proteins. Molecular and Cellular Biology, 19(11):7589–7599, November 1999. URL: http://dx.doi.org/10.1128/mcb.19.11.7589, doi:10.1128/mcb.19.11.7589. This article has 110 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.19.11.7589)